Date	Period	Revenue/Estimate	Earnings Call
Aug 9, 2024	2025/Q1	100.000M / --	--
Feb 9, 2024	2024/Q3	110.000M / --	--
Aug 10, 2023	2024/Q1	148.000M / --	--
Feb 10, 2023	2023/Q3	185.000M / --	--
Aug 5, 2022	2023/Q1	385.000M / --	--

DatePeriodRevenue/EstimateEarnings Call

Aug 9, 20242025/Q1100.000M / ----

Feb 9, 20242024/Q3110.000M / ----

Aug 10, 20232024/Q1148.000M / ----

Feb 10, 20232023/Q3185.000M / ----

Aug 5, 20222023/Q1385.000M / ----

Unlock Free Earnings Estimates

Open Account

OncoTherapy Science Earnings Reports

OncoTherapy Science: Confirmation letter

Nov 10 19:25 ET

OncoTherapy Science: Interim report - 24th term (2024/04/01 - 2025/03/31)

Nov 10 19:23 ET

OncoTherapy Science: Summary of financial results for the 2nd quarter (interim period) of the fiscal year ending 2025/3 [Japanese GAAP] (consolidated)

Nov 8 03:00 ET

OncoTherapy Science: Announcements of individual stocks regarding the occurrence of non-operating expenses.

Aug 9 04:00 ET

Symbol Price % Chg

Beauty Kadan Holdings